Degree | Department/Program | Institute | Year |
2003 | |||
2007 | |||
2012 |
1. Cytokine Gene Polymorphism in Tuberculosis Patients and Genetic Susceptibility, Supervisor: Dr. Gürol EMEKDAŞ, Mersin University, Graduate School of Health Sciences, Microbiology Department, Mersin, Turkey, 2012.
Theses_002.pdf
1. Characterization of rpsL and rrs Gene Region Mutations in Streptomycin Resistance Mycobacterium tuberculosis Complex Isolates with DNA Sequence Analyses in Mersin Province, Supervisor: Dr. Gönül ASLAN, Mersin University, Graduate School of Health Sciences, Microbiology Department, Mersin, Turkey, 2007.
Theses_001.pdf
Title | Institute | Year |
LECTURER | MERSIN UNIVERSITY | 2009-02-11 - 2013-02-22 |
ASISST. PROF. DR. | MERSIN UNIVERSITY | 2013-02-22 - 2018-03-06 |
DOCTOR LECTURER | MERSIN UNIVERSITY | 2018-03-06 - Continue |
Title | Dutie | Institution/Other | Year |
2016-08-23 - 2019-08-23 | |||
2016-08-01 - 2019-08-01 | |||
2016-08-01 - 2019-08-01 | |||
2016-08-01 - 2019-08-01 | |||
2015-02-11 - 2018-02-11 | |||
2015-02-11 - 2018-02-11 |
2020
35. Kirik, F.; Ülger, M.; Tezcan Ülger, S.; Aslan, G. Association of cytokine gene polymorphisms with susceptibility to cutaneous leishmaniasis in a Turkish population. PARASITE IMMUNOL, 2020, 13, 12775-12775. 850 + 0Publications_046.pdf
34. Belveren, S.; Poyraz, S.; Ülger, M.; Pask, C.; Döndaş, H.; Sansano, J. Synthesis, structure and bioactivity of a mononuclear octahedral [Prolinate2-Na(MeOH)4]−H+ complex. INORGANICA CHIMICA ACTA, 2020, 504, 119456-119456. 650 + 010.1016/j.ica.2020.119456
Publications_044.pdf
33. Güzel, S.; Ülger, M.; Kahraman, A. Chemical Composition and Some Biological Activities of Salvia longipedicellata Hedge Mericarps. CHEMISTRY OF NATURAL COMPOUNDS, 2020, 56, 788-792. 1000 + 010.1007/s10600-020-03153-5
Publications_047.pdf
2019
32. Gemili, M.; Nural, Y.; Keles, E.; Aydiner, B.; Seferoglu, N.; Ulger, M.; Sahin, E.; Erat, S.; Seferoglu, Z. Novel highly functionalized 1,4-naphthoquinone 2-iminothiazole hybrids: Synthesis, photophysical properties, crystal structure, DFT studies, and anti(myco)bacterial/antifungal activity. JOURNAL OF MOLECULAR STRUCTURE, 2019, 1196, 536-546. 200 + 0https://dx.doi.org/10.1016/j.molstruc.2019.06.087
31. Guzel, S.; Ozay, Y.; Kumas, M.; Uzun, C.; Ozkorkmaz, E.; Yildirim, Z.; Ulger, M.; Guler, G.; Celik, A.; Camlica, Y. Wound healing properties, antimicrobial and antioxidant activities of Salvia kronenburgii Rech. f. and Salvia euphratica Montbret, Aucher & Rech. f. var. euphratica on excision and incision wound models in diabetic rats. BIOMEDICINE & PHARMACOTHERAPY, 2019, 111, 1260-1276. 100 + 6https://dx.doi.org/10.1016/j.biopha.2019.01.038
Publications_038.pdf
30. TEZCAN ÜLGER, S.; KURNAZ, N.; ÜLGER, M.; ASLAN, G.; EMEKDAŞ, G. Serological Evidence of Rift Valley Fever Virus Among Humans in Mersin Province of Turkey. J VECTOR BORNE DIS, 2019, 56, 373-379. 700 + 0Publications_042.pdf
29. BELVEREN, S.; Larrañaga, O.; POYRAZ, S.; DÖNDAŞ, H.; ÜLGER, M.; ŞAHİN, E.; Ferrándiz-Saperas, M.; Sansano, J.; Gracia Retamosa, d.; de Cozar, A. From Bioactive Pyrrolidino[3,4-c]pyrrolidines to more Bioactive Pyrrolidino[3,4-b]pyrrolidines via Ring-Opening/Ring-Closing Promoted by Sodium Methoxide. SYNTHESIS, 2019, 51, 1595-1577. 250 + 010.1055/s-0037-1611356
28. Belveren, S.; Poyraz, S.; Pask, C.; Ülger, M.; Sansano, J.; Ali Döndaş, H. Synthesis and biological evaluation of platinum complexes of highly functionalized aroylaminocarbo-N-thioyl prolinate containing tetrahydropyrrolo[3,4-c]pyrrole-1,3(2H,3aH)-dione moieties. INORGANICA CHIMICA ACTA, 2019, 498, 119154-119154. 550 + 0http://dx.doi.org/10.1016/j.ica.2019.119154
2018
27. NURAL, Y.; GEMİLİ, M.; ÜLGER, M.; SARI, H.; DE COEN, L.; ŞAHİN, E. Synthesis, antimicrobial activity and acid dissociation constants of methyl 5,5-diphenyl-1-(thiazol-2-yl)pyrrolidine-2-carboxylate derivatives. BIOORGANIC MEDICINAL CHEMISTRY LETTERS, 2018, 28, 942-946. 650 + 2010.1016/j.bmcl.2018.01.045
Times Cited: 4
26. DÜNDAR, Y.; ÜLGER, M.; KAYNAK ONURDAĞ, F.; ÖKTEN, S.; ÖNKOL, T. . REV. ROUM. CHIM., 2018, 63, 265-272. 800 + 0
25. AKÇAY, S.; ÜLGER, M.; KAYNAK ONURDAĞ, F.; DÜNDAR, Y. . ACTA CHIMICA SLOVENICA, 2018, 65, 932-938. 850 + 010.17344/acsi.2018.4590
24. Nural, Y.; Gemili, M.; Seferoglu, N.; Sahin, E.; Ulger, M.; Sari, H. Synthesis, crystal structure, DFT studies, acid dissociation constant, and antimicrobial activity of methyl 2-(4-chlorophenyl)-7a-((4-chlorophenyl)carbamothioyl)-1-oxo-5,5-diphenyl-3-thioxo-hexahydro-1H-pyrrolo[1,2-e]imidazole-6-carboxylate. JOURNAL OF MOLECULAR STRUCTURE, 2018, 1160, 375-382. 450 + 25http://dx.doi.org/10.1016/j.molstruc.2018.01.099
Publications_037.pdf
Times Cited: 5
23. POYRAZ, S.; CANACANKATAN, N.; BELVEREN, S.; YETKİN, D.; Kibar, K.; ÜLGER, M.; Sansano, J.; ÖZÇELİK, N.; YILMAZ, Ş.; DÖNDAŞ, H. Study of the anti(myco)bacterial and antitumor activities of prolinate and N-amidocarbothiolprolinate derivatives based on fused tetrahydropyrrolo[3,4-c]pyrrole-1,3(2H,3aH)-dione, bearing an indole ring. MONATSHEFTE FUR CHEMIE - CHEMICAL MONTHLY, 2018, 149, 2253-2263. 150 + 1010.1007/s00706-018-2286-8
Times Cited: 2
22. NURAL, Y.; GEMİLİ, M.; YABALAK, E.; DE COEN, L.; ÜLGER, M. Green synthesis of highly functionalized octahydropyrrolo[3,4-c]pyrrole derivatives using subcritical water, and their anti(myco)bacterial and antifungal activity. ARKIVOC, 2018, 2018, 51-64. 500 + 1310.24820/ark.5550190.p010.573
Times Cited: 2
2017
21. ERŞEN, D.; ÜLGER, M.; MANGELINCKX, S.; GEMİLİ, M.; ŞAHİN, E.; NURAL, Y. Synthesis and anti(myco)bacterial activity of novel 5,5-diphenylpyrrolidine N-aroylthiourea derivatives and a functionalized hexahydro-1H-pyrrolo[1,2-c]imidazole. MEDICINAL CHEMISTRY RESEARCH, 2017, 26, 2152-2160. 750 + 7010.1007/s00044-017-1907-9
Publications_028.pdf
Times Cited: 14
20. Belveren, S.; Dondas, H.; Ülger, M.; Poyraz, S.; Garcia-Mingüens, E.; Ferrandiz-Saperas, M.; Sansano, J. Synthesis of highly functionalized 2-(pyrrolidin-1-yl)thiazole frameworks with interesting antibacterial and antimycobacterial activity. TETRAHEDRON, 2017, 73, 6718-6727. 600 + 3510.1016/j.tet.2017.10.007
Publications_033.pdf
Times Cited: 7
19. Burmaoglu, S.; Algul, O.; Gobek, A.; Anil, D.; Ulger, M.; Erturk, B.; Kaplan, E.; Dogen, A.; Aslan, G. Design of potent fluoro-substituted chalcones as antimicrobial agents. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2017, 32, 490-495. 300 + 2510.1080/14756366.2016.1265517
Publications_025.pdf
Times Cited: 5
18. GEMİLİ, M.; SARI, H.; ÜLGER, M.; ŞAHİN, E.; NURAL, Y. Pt(II) and Ni(II) complexes of octahydropyrrolo[3,4-c]pyrrole N-benzoylthiourea derivatives: Synthesis, characterization, physical parameters and biological activity. INORGANICA CHIMICA ACTA, 2017, 463, 88-96. 700 + 85http://dx.doi.org/10.1016/j.ica.2017.04.026
Publications_030.pdf
Times Cited: 17
17. Poyraz, S.; Belveren, S.; Ulger, M.; Sahin, E.; Dondas, H. Synthesis, characterization, crystal structure, and antituberculosis activity of some novel polysubstituted aminocarbothiol/thiohydantoin-pyrrolidine derivatives. MONATSHEFTE FUR CHEMIE, 2017, 148, 2173-2182. 700 + 2010.1007/s00706-017-2039-0
Publications_032.pdf
Times Cited: 4
2016
16. Direkel, Ş.; Karaman, Ü.; Tezcan, S.; Utku, S.; Aslan, G.; Uysal, M.; Şahin, M.; Delialioğlu, N.; Ülger, M.; Emekdaş, G. Investigation of Anti-leishmanial Activity of the Ten Different Hydrazone Derivatives. KAFKAS UNIV VET FAK DERG, 2016, 22, 519-524. 100 + 1010.9775/kvfd.2016.14967
Publications_022.pdf
Times Cited: 2
2015
15. Tezcan, S.; Ulger, M.; Ucbilek, E.; Aslan, G.; Serin, M.; Sezgin, O.; Delialioglu, N.; Altintas, E.; Helvaci, I.; Emekdas, G. Characterization of Basal Core Promoter/Precore Gene Mutations in Chronically Infected Patients with Hepatitis B Virus Genotype D in Mersin Province, Turkey. MIKROBIYOLOJI BULTENI, 2015, 49, 377-392. 550 + 8Publications_012.pdf
Times Cited: 1
14. Tezcan, S.; Dincer, E.; Ulger, M.; Ozgur, D.; Erdogan, S.; Ozkul, A.; Emekdas, G.; Ergunay, K. Serological Investigation of Phlebovirus Exposure in Blood Donors from the Mediterranean Province of Mersin, Turkey. MIKROBIYOLOJI BULTENI, 2015, 49, 403-413. 550 + 25Publications_013.pdf
Times Cited: 5
2014
13. Giray, B.; Emekdas, G.; Tezcan, S.; Ulger, M.; Serin, M.; Sezgin, O.; Altintas, E.; Tiftik, E. Profiles of serum microRNAs; miR-125b-5p and miR223-3p serve as novel biomarkers for HBV-positive hepatocellular carcinoma. MOLECULAR BIOLOGY REPORTS, 2014, 41, 4513-4519. 450 + 370https://dx.doi.org/10.1007/s11033-014-3322-3
Publications_002.pdf
Times Cited: 74
12. Tezcan, S.; Kizildamar, S.; Ulger, M.; Aslan, G.; Tiftik, N.; Ozkul, A.; Emekdas, G.; Niedrig, M.; Ergunay, K. Flavivirus Seroepidemiology in Blood Donors in Mersin Province, Turkey. MIKROBIYOLOJI BULTENI, 2014, 48, 606-617. 500 + 30Publications_001.pdf
Times Cited: 6
11. Gulbudak, H.; Aslan, G.; Tezcan, S.; Ersoz, G.; Ulger, M.; Otag, F.; Kuyucu, N.; Emekdas, G. Investigation of The Clonal Relationship Between Nosocomial Acinetobacter baumannii Isolates by Rep-PCR. MIKROBIYOLOJI BULTENI, 2014, 48, 316-324. 350 + 5Publications_003.pdf
Times Cited: 1
10. Ozcelik, A.; Ulger, M.; Aslan, G.; Emekdas, G.; Ozden, T. STUDIES ON IN VITRO ANTIMYCOBACTERIAL ACTIVITIES OF SOME 2-SUBSTITUTEDIMIDAZO[4,5-b] AND [4,5-c]PYRIDINE DERIVATIVES. REVUE ROUMAINE DE CHIMIE, 2014, 59, 5-8. 800 + 0Publications_004.pdf
9. Tezcan, S.; Ozgur, D.; Ulger, M.; Aslan, G.; Gurses, I.; Serin, M.; Giray, B.; Dilek, S.; Emekdas, G. Human Papillomavirus Genotype Distribution and E6/E7 Oncogene Expression in Turkish Women with Cervical Cytological Findings. ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15, 3997-4003. 500 + 5610.7314/APJCP.2014.15.9.3997
Publications_004.pdf
Times Cited: 10
2013
8. Tezcan, S.; Ulger, M.; Aslan, G.; Yaras, S.; Altintas, E.; Sezgin, O.; Emekdas, G.; Gurer Giray, B.; Sungur, M. Determination of Hepatitis C Virus Genotype Distribution in Mersin Province, Turkey. MIKROBIYOLOJI BULTENI, 2013, 47, 332-338. 600 + 109Publications_015.pdf
Times Cited: 20
7. Ulger, M.; Emekdas, G.; Aslan, G.; Tas, D.; Ilvan, A.; Tezcan, S.; Calikoglu, M.; Erdal, M.; Kartaloglu, Z. Determination of the Cytokine Gene Polymorphism and Genetic Susceptibility in Tuberculosis Patients. MIKROBIYOLOJI BULTENI, 2013, 47, 250-264. 700 + 45Publications_005.pdf
Times Cited: 9
2012
6. Aydin, F.; Ulger, M.; Emekdas, G.; Aslan, G.; Gunal, S. Isolation and Identification of Mycobacterium bovis and Non-tuberculous Mycobacteria in Raw Milk Samples in Mersin Province. MIKROBIYOLOJI BULTENI, 2012, 46, 283-289. 800 + 30Publications_016.pdf
Times Cited: 6
5. Direkel, S.; Otag, F.; Aslan, G.; Ulger, M.; Emekdas, G. Identification of Filamentous Fungi Isolated from Clinical Samples by Two Different Methods and Their Susceptibility Results. MIKROBIYOLOJI BULTENI, 2012, 46, 65-78. 600 + 15Publications_018.pdf
Times Cited: 3
4. Emekdas, G.; Tezcan, S.; Aslan, G.; Serin, M.; Sezgin, O.; Ucbilek, E.; Ulger, M.; Altintas, E.; Dogen, A. Determination of Hepatitis B Virus Genotypes in Chronic Hepatitis B Patients in Mersin Province, Turkey. MIKROBIYOLOJI BULTENI, 2012, 46, 432-445. 100 + 25Publications_017.pdf
Times Cited: 5
2011
3. Utku, S.; Gokce, M.; Aslan, G.; Bayram, G.; Ulger, M.; Emekdas, G.; Sanhin, M. Synthesis and in vitro antimycobacterial activities of novel 6-substituted-3(2H)-pyridazinone-2-acetyl-2-(substituted/nonsubstituted acetophenone) hydrazone. TURKISH JOURNAL OF CHEMISTRY, 2011, 35, 331-339. 400 + 30https://dx.doi.org/10.3906/kim-1009-63
Publications_019.pdf
Times Cited: 6
2009
2. Ulger, M.; Aslan, G.; Emekdas, G.; Tezcan, S.; Serin, M. INVESTIGATION OF rpsL AND rrs GENE REGION MUTATIONS IN STREPTOMYCIN RESISTANT MYCOBACTERIUM TUBERCULOSIS COMPLEX ISOLATES. MIKROBIYOLOJI BULTENI, 2009, 43, 115-120. 900 + 20Publications_008.pdf
Times Cited: 4
2007
1. Yildiz, C.; Ulger, M.; Aslan, G.; Emekdas, G. Isoniazid susceptibilities of Mycobacterium tuberculosis on blood agar. SAUDI MEDICAL JOURNAL, 2007, 28, 975-977. 850 + 15Publications_020.pdf
Times Cited: 3
2020
4. Aslan, G.; Kurnaz, N.; Ülger, M.; Ayan, İ.; Tok Umay, S.; Gürses, İ. Retrospective Evaluation of 14 Patients with Bone and Joint Tuberculosis in Mersin, Turkey. FLORA, 2020, 25, 197-205. 195 + 010.5578/flora.68767
Publications_048.pdf
2019
3. Güzel, S.; Kahraman, A.; Ülger, M.; Özay, Y.; Bozgeyik, İ.; Sarıkaya, Ö. Morphology, myxocarpy, mineral content and in vitro antimicrobial and antiproliferative activities of mericarps of the vulnerable Turkish endemic Salvia pilifera.. JOURNAL OF RESEARCH IN PHARMACY, 2019, 23, 729-739. 195 + 0Publications_039.pdf
2018
2. GÜZEL ÖZAY, S.; ÜLGER, M.; ASLAN, G.; KÖKDİL, G. . JOURNAL OF RESEARCH IN PHARMACY, 2018, 22, 37-45. 255 + 010.12991/jrp.2018.76
1. ASLAN, G.; ÜLGER, M.; TEZCAN ÜLGER, S.; DURUKAN, H.; YAZICI, F.; EMEKDAŞ, G. . INTERNATIONAL JOURNAL OF REPRODUCTIVE BIOMEDICINE, 2018, 16, 57-60. 0 + 0
1. GÜZEL ÖZAY, S.; KÖKDİL, G.; ÜLGER, M. . INTERNATIONAL JOURNAL OF SCIENTIFIC AND TECHNOLOGICAL RESEARCH, 2018, 4, 27-38. 100 + 0
2019
13. Güzel, S.; Ülger, M.; Özay, Y.; Yumrutaş, Ö.; Bozgeyik, İ.; Sarıkaya, Ö. Antimicrobial and Antiproliferative Activities of Vincetoxicum canescens subsp. canescens and Vincetoxicum cancescens subsp. pedunculata Seeds. LOKMAN HEKIM DERGISI, 2019, 9, 367-375. 150 + 0Publications_041.pdf
12. Ülger, M.; Kurnaz, N.; Tezcan Ülger, S.; Delialioğlu, N.; Aslan, G. Retrospective Evaluation of 38 Patients with Tuberculous Pleurisy in Mersin. TURK MIKROBIYOLOJI CEM DERG, 2019, 49, 132-139. 180 + 0Publications_040.pdf
2018
11. ÖZER, S.; KONUCU, M.; ALTUNTAŞ, H.; GÜLEŞEN, R.; LEVENT, B.; ÜLGER, M. . EGE JOURNAL OF FISHERIES AND AQUATIC SCIENCES, 2018, 35, 373-381. 80 + 010.12714/egejfas.2018.35.4.02
10. DOĞAN ÇALHAN, S.; ÜLGER, M. . MERSIN UNIVERSITESI SAGLIK BILIMLERI DERGISI, 2018, , -. 200 + 0
2017
9. Yarpuzlu, M.; Aslan, G.; Ülger, M.; Tezcan Ülger, S.; Emekdaş, G.; Kuyucu, N.; Kaya, A. Investigation of Bacterial Meningitis Agents from Patients with Suspicion of Non-Neonatal Meningitis by Conventional and Molecular Methods. TURK MIKROBIYOLOJI CEMIYETI DERGISI, 2017, 47, 205-212. 120 + 0Publications_036.pdf
8. Aslan, G.; Ülger, M.; Delialioğlu, N.; Otağ, Z.; Düşmez Apa, D.; Ersöz, G.; Köksel, O.; Doruk, E.; Kuyucu, N.; Özcan, C. Microbiologic and Demographic Evaluation of Extrapulmonary Tuberculosis Cases in Mersin Province. TURK MIKROBIYOLOJI CEMIYETI DERGISI, 2017, 47, 197-204. 110 + 0Publications_035.pdf
2013
7. Yarpuzlu, M.; Ulger, M.; Aslan, G.; Tezcan, S.; Koksel, O.; Calikoglu, M.; Ilvan, A.; Emekdas, G. Evaluation of 69 Tuberculous Pleurisy Patients and Their Antituberculosis Drug Susceptibilities. ANKEM DERGISI, 2013, 27, 31-37. 130 + 0http://dx.doi.org/10.5222/ankem.2013.031
Publications_010.pdf
2012
6. Gumustekin, S.; Tezcan, S.; Ulger, M.; Tiftik, E.; Serin, M.; Aslan, G.; Emekdas, G. An Investigation on the Presence of Parvovirus B19 in the Patients with Hematological Malignancies. MERSIN UNIVERSITESI SAGLIK BILIMLERI DERGISI, 2012, 5, 24-29. 120 + 0Publications_011.pdf
2011
5. Seda, T.; Mahmut, U.; Gurol, E. West Nile Virus and Infection. MERSIN UNIVERSITESI SAGLIK BILIMLERI DERGISI, 2011, 4, 9-17. 0 + 0Publications_014.pdf
2010
4. Dagdartan, U.; Ulger, M.; Aslan, G.; Emekdas, G. Evaluation of a Case with Tuberculous Pleurisy. MERSIN UNIVERSITESI SAGLIK BILIMLERI DERGISI, 2010, 3, 39-41. 85 + 0Publications_009.pdf
2009
3. Aslan, G.; Kuyucu, N.; Calıkoglu, M.; Ersoz, G.; Ulger, M.; Gunal, S.; Emekdas, G. Tuberculosis Cases Caused by Mycobacterium bovis. ANKEM DERGISI, 2009, 23, 182-187. 80 + 0Publications_021.pdf
2007
2. Aslan, G.; Emekdas, G.; Dusmez Apa, D.; Cordan Yazıcı, A.; Kokturk, A.; Ersoz, G.; Unal, M.; Ulger, M. The Identification and Antituberculosis Susceptibility of Mycobacteria Isolated from Tuberculosis Lymphadenitis Cases. ANKEM DERGISI, 2007, 21, 27-31. 20 + 3Publications_007.pdf
1. Aslan, G.; Emekdas, G.; Ulger, M.; Tezcan, S.; Kaya, A.; Doğu, O.; Kuyucu, N. Usage of Polymerase Chain Reaction in The Diagnosis of Tuberculous Meningitis. TURK MIKROBIYOLOJI CEMIYETI DERGISI, 2007, 37, 204-208. 120 + 0Publications_006.pdf
2020
1. Güzel, S.; Ülger, M.; Özay, Y. Antimicrobial and Antiproliferative Activities of Chia (Salvia hispanica L.) Seeds. INTERNATIONAL JOURNAL OF SECONDARY METABOLITE, 2020, 7, 174-180. 100 + 010.21448/ijsm.722574
Publications_049.pdf
2018
1. GÜZEL ÖZAY, S.; ÖZAY, Y.; ÜLGER, M.; KAHRAMAN, A.; ASLAN, G. . HACETTEPE UNIVERSITY JOURNAL OF THE FACULTY OF PHARMACY, 2018, 38, 4-10. 70 + 0
1. ÜLGER, M. Koneman’s Color Atlas and Textbook of Diagnostic Microbiology, ISBN: 978-145-1116-59-5, Hipokrat Kitabevi, Number of print: 7, Total Printing Number: 700, 2 Page, Turkish, Ankara, Turkey, 2017. 50
2. ÜLGER, M. Koneman’s Color Atlas and Textbook of Diagnostic Microbiology, ISBN: 978-145-1116-59-5, Hipokrat Kitabevi, Number of print: 7, Total Printing Number: 700, 3 Page, Turkish, Ankara, Turkey, 2017. 50
3. ÜLGER, M. Koneman’s Color Atlas and Textbook of Diagnostic Microbiology, ISBN: 978-145-1116-59-5, Hipokrat Kitabevi, Number of print: 7, Total Printing Number: 700, 3 Page, Turkish, Ankara, Turkey, 2017. 50
1. Kırık, F.; Ülger, M.; Özkan, O.; Öztürk, A.; Aslan, G., Türkiye’de Endemik Hypericum crenulatum Boiss. ve Lysimachia savranii Bitkilerinin in vitro Antimikrobiyal Aktiviteleri. III. International Scientific and Vocational Studies Congress-Science and Health (BILMES-SH 2019), 2019-06-27, 2019-06-30, Nevşehir, Turkey, 2019. 160
Scientific_Meetings_024.pdf
14. Döndaş, H.; Poyraz, S.; Belveren, S.; Ülger, M., Synthesis, Characterization and Anti(myco) bacterial Activities of Some Novel Nickel (II) Complexes of Dimethyl Benzoylcarbamothioyl Pyrrolidine Dicarboxylate Derivatives. V. International Scientific and Vocational Studies Congress – Science and Health (BILMES SH 2020), 2020-12-12, 2020-12-15, Mersin, Turkey, 2020. 65
13. Döndaş, H.; Belveren, S.; Poyraz, S.; Ülger, M., Preparation, Characterization and Bioactivities of Some Novel Cupper and Palladium Complexes of Indol/Methyl Pyrrolidine Aminocarbothiol Derivatives. V. International Scientific and Vocational Studies Congress – Science and Health (BILMES SH 2020), 2020-12-12, 2020-12-15, Mersin, Turkey, 2020. 65
12. Ülger, M.; Kurnaz, N.; Kaya, H.; Kaya, E.; Sezer, O.; Aslan, G., Mycobacterium tuberculosis Kompleks Klinik İzolatlarında Amikasin, Moksifloksasin ve Kanamisin İlaç Duyarlılıklarının Araştırılması. Uluslararası Mikobakteri Sempozyumu, 2019-11-28, 2019-11-30, Mersin, Turkey, 2019. 85
Scientific_Meetings_031.pdf
11. Ülger, M.; Poyraz, S.; Karataş, E.; Belveren, S.; Gizir, A.; Döndaş, H., Yeni İmidazol-Pirolinat Türevlerinin Antitüberküloz Aktivitelerinin Araştırılması. Uluslararası Mikobakteri Sempozyumu, 2019-11-28, 2019-11-30, Mersin, Turkey, 2019. 85
Scientific_Meetings_033.pdf
10. Biltekin, N.; Ülger, M.; Kayar, B.; Yakıcı, G.; Tezcan Ülger, S.; Aslan, G.; Delialioğlu, N., Bir Üniversite Hastanesinden İzole Edilen Mycobacterium tuberculosis Kompleks İzolatlarının Moleküler Yöntemler ile Genotiplendirilmesi. Uluslararası Mikobakteri Sempozyumu, 2019-11-28, 2019-11-30, Mersin, Turkey, 2019. 65
Scientific_Meetings_032.pdf
9. Bayram Abiha, G.; Utku, S.; Ülger, M.; Aslan, G., Study on Antimycobacterial Activities of Michael-type Addition Products. Uluslararası Mikobakteri Sempozyumu, 2019-11-28, 2019-11-30, Mersin, Turkey, 2019. 75
Scientific_Meetings_029.pdf
8. Ersoy, L.; Özçimen, A.; Ülger, M.; Çalıkoğlu, M.; Aslan, G., Tüberküloz Hastalarında SOCS-1 Gen Polimorfizmlerinin Araştırılması. Uluslararası Mikobakteri Sempozyumu, 2019-11-28, 2019-11-30, Mersin, Turkey, 2019. 70
Scientific_Meetings_030.pdf
7. Poyraz, S.; Belveren, S.; Ülger, M.; Döndaş, H., Kromon/İndol Farmakofor Grupları Bulunduran Yeni Tiyazolpirolidin Türevlerinin Sentezi, Karakterizasyonu ve Biyolojik Aktiviteleri. III. International Scientific and Vocational Studies Congress-Science and Health (BILMES-SH 2019), 2019-06-27, 2019-06-30, Nevşehir, Turkey, 2019. 75
Scientific_Meetings_026.pdf
6. Ülger, M.; Kırık, F.; Özkan, O.; Öztürk, A.; Aslan, G., Niğde İli Endemik Hypericum crenulatum ve Lysimachia savranii Bitkilerinin in vitro Antimikobakteriyel Aktivitelerinin Araştırılması. III. International Scientific and Vocational Studies Congress-Science and Health (BILMES-SH 2019), 2019-06-27, 2019-06-30, Nevşehir, Turkey, 2019. 90
Scientific_Meetings_025.pdf
5. TEZCAN ÜLGER, S.; ÖZGÜR, D.; YARAŞ, S.; ÜLGER, M.; SEZGİN, O.; ASLAN, G., Helicobacter pylori Pozitif Mide Biyopsi Örneklerinde Human Papillomavirus Varlığının Belirlenmesi. Uluslararası 38. Türk Mikrobiyoloji Kongresi, 2018-11-04, 2018-11-08, ANTALYA, Turkey, . 55
4. ÜLGER, M.; FIRAT YENER, P.; TEZCAN ÜLGER, S.; ÖZGÜR, D.; ASLAN, G., Investigation of Toll-Like Receptors 2 and 4 Gene Polymorphisms with PCR-RFLP and DNA Sequencing in Tuberculosis Patients. 3rd International Mediterranean Science and Engineering Congress (IMSEC 2018), 2018-10-24, 2018-10-26, ADANA, Turkey, . 90
3. ÜLGER, M., Antibacterial and Antimycobacterial Activity of 5,5-Diphenylpyrrolidine N-aroylthiourea Derivatives. International Eurasian Conference on Biological and Chemical Sciences, 2018-04-26, 2018-04-27, Ankara, Turkey, 2018. 100
Scientific_Meetings_023.pdf
2. Serin, M.; Sezgin, O.; Öksüz, Z.; Gürer Giray, B.; Altıntaş, E.; Tiftik, E.; Döğen, A., Biomarker Potential of Several miRNAs For The Early Diagnosis of Hepatocellular Carcinoma Related With HBV and HCV Infections. Drug Discovery and Therapy World Congress, 2017-07-10, 2017-07-13, Boston, United States of America, 2017. 10
Scientific_Meetings_012.pdf
1. Aydın, F.; Ülger, M.; Tezcan Ülger, S.; Aslan, G., Cytokine Gene Polymorphisms and Genetic Susceptibility in Cutaneous Leishmaniasis Patients. International Symposium on Parasitic Zoonozes, 2016-11-18, 2016-11-19, Antalya, Turkey, 2016. 85
Scientific_Meetings_008.pdf
20. Bulut, G.; Dogan, A.; Haznedaroğlu, M.; Senkardes, I.; Ulger, M.; Satıroglu, A.; Can Emmez, B., A cretan song on Taurus Mountains: medicinal and edible plants of Ihsaniye village (Mersin - Turkey). XVI Optima Meeting, 2019-10-02, 2019-10-05, Athens, Greece, 2019. 17
Scientific_Meetings_034.pdf
19. Belveren, S.; Poyraz, S.; Ülger, M.; Döndaş, H., Functionalised Bicyclic Fused Pyrrole-4,6-Dion Ring System Possess Zwitterion and Pharmacophore Moieties on The Structure; Synthesis, Characterization and Bioactivities. International Multidisciplinary Symposium on Drug Research & Development (DRD 2019), 2019-07-01, 2019-07-03, Malatya, Turkey, 2019. 37
Scientific_Meetings_027.pdf
18. Poyraz, S.; Belveren, S.; Ülger, M.; Döndaş, H., Palladium Complexes of Substitued N-(Pyrrolidine-1-Carbonothioyl)Benzamide and Their Anti(Myco) Bacterial, Antifungal Activities. International Multidisciplinary Symposium on Drug Research & Development (DRD 2019), 2019-07-01, 2019-07-03, Malatya, Turkey, 2019. 37
Scientific_Meetings_028.pdf
17. OKTAY, E.; ÜLGER, M.; YABALAK, E.; KURNAZ, N.; TEZCAN ÜLGER, S.; DELİALİOĞLU, N.; GİZİR, A., Investigation of in vitro Antituberculosis Activity of the Plant Extracts from St. Johnʼs wort (Hypericum perforatum L.) and Aloe vera.. 39th Annual Conrgress of the European Society of Mycobacteriology, 2018-07-01, 2018-07-04, Dresden, Germany, . 32
16. Poyraz, S.; Belveren, S.; Ülger, M.; Döndaş, H., Synthesis and Some Biological Evaluation of Novel Heterocycles Bearing Indole/Pyyrolidine Ring System and/or Aminocarbothiol Moiety. 5th International BAU Drug Design Congress, 2017-10-19, 2017-10-21, İstanbul, Turkey, 2017. 37
Scientific_Meetings_020.pdf
15. Belveren, S.; Poyraz, S.; Ülger, M.; Döndaş, H., Synthesis and Biological Evaluation of Pyyrolidine-Thiazoles/Indole Ring System Containing Heterocycles. 5th International BAU Drug Design Congress, 2017-10-19, 2017-10-21, İstanbul, Turkey, 2017. 37
Scientific_Meetings_021.pdf
14. Poyraz, S.; Belveren, S.; Ulger, M.; Dondas, H., Synthesis and Antituberculosis Activity of Indol-3-yl-alkyl-2-(4-Chlorophenyl)-5-alkyl-4,6-Dioxooctahydropyrrolo[3,4-B]Pyrrole-3-Carboxylate. 2nd International Gazi Pharma Symposium, 2017-10-11, 2017-10-13, Ankara, Turkey, 2017. 37
Scientific_Meetings_017.pdf
13. Kupeli, E.; Okkay, O.; Ersan, R.; Ulger, M.; Gonca, S.; Tezcan Ulger, S.; Dogen, A., Design and Synthesis of Some Amid Bridge Carried Bis-Benzazole Compounds and Investigation on Their Antifungal and Antituberculos Activities. 2nd International Gazi Pharma Symposium, 2017-10-11, 2017-10-13, Ankara, Turkey, 2017. 22
Scientific_Meetings_019.pdf
12. Utku, S.; Bayram Abiha, G.; Ulger, M.; Uysal, M.; Aslan, G.; Emekdas, G., Synthesis and in vitro Antimycobacterial Activities of 6-Substituted-3(2H)-Pyridazinone-2-Acetyl-2-(Substituted/Nonsubstituted Acetophenone)Hydrazone. 2nd International Gazi Pharma Symposium, 2017-10-11, 2017-10-13, Ankara, Turkey, 2017. 32
Scientific_Meetings_016.pdf
11. Belveren, S.; Poyraz, S.; Ulger, M.; Dondas, H., Synthesis, Characterisation of Aminocarbothiol Pyrrolidine-Pt(II) Complexes; Their Antibacterial and Antituberculosis Activity. 2nd International Gazi Pharma Symposium, 2017-10-11, 2017-10-13, Ankara, Turkey, 2017. 37
Scientific_Meetings_018.pdf
10. Ülger, M.; Özgür, D.; Kurnaz, N.; Delialioğlu, N.; Akar, A.; Kuyucu, N.; Gürses, İ., Ten Years of Pediatric Tuberculosis: A Retrospective Study in Mersin, Turkey. 38th Annual Congress of the European Society of Mycobacteriology, 2017-06-25, 2017-06-28, Sibenik, Croatia, 2017. 37
Scientific_Meetings_014.pdf
9. Aslan, G.; Kurnaz, N.; Ülger, M.; Özgür, D.; Tezcan Ülger, S.; Tok, S.; Delialioğlu, N., Retrospective Evaluation of 11 Patients with Bone and Joint Tuberculosis in Mersin, Turkey. 38th Annual Congress of the European Society of Mycobacteriology, 2017-06-25, 2017-06-28, Sibenik, Croatia, 2017. 27
Scientific_Meetings_013.pdf
8. Özgür, D.; Ülger, M.; Kayar, B.; Tezcan Ülger, S.; Ersoy, L.; Aslan, G.; Köksal, F., Investigation of Pyrazinamide Resistance in Drug Resistant Mycobacterium tuberculosis complex in Turkey. 38th Annual Congress of the European Society of Mycobacteriology, 2017-06-25, 2017-06-28, Sibenik, Croatia, 2017. 35
Scientific_Meetings_015.pdf
7. Dundar, Y.; Ülger, M.; Kaynak Onurdag, F.; Onkol, T., Synthesis and Antibacterial and Antitubercular Activity of Ofloxacin Derivatives. 17th Hellenic Symposium on Medicinal Chemistry, 2017-06-01, 2017-06-03, Thessaloniki, Greece, 2017. 42
Scientific_Meetings_022.pdf
6. Tezcan Ülger, S.; Ülger, M.; Durukan, H.; Özgür, D.; Delialioğlu, N.; Ertabaklar, H.; Aslan, G., Determination of the Presence of Trichomonas vaginalis and Coexistance with HPV on Cervical Cytological Samples. International Symposium on Parasitic Zoonozes, 2016-11-18, 2016-11-19, Antalya, Turkey, 2016. 35
Scientific_Meetings_011.pdf
5. Poyraz, S.; Belveren, S.; Erşen, D.; Gemili, M.; Ülger, M.; Döndaş, H., Synthesis, characterization and antituberculosis activity of novel substitued thiohydantoin pyrrolidine derivatives. 4th International BAU Drug Desing Congres, 2016-10-13, 2016-10-15, İstanbul, Turkey, 2016. 22
Scientific_Meetings_010.pdf
4. Belveren, S.; Gemili, M.; Poyraz, S.; Ülger, M.; Döndaş, H., Antibacterial Activity of Bicyclic Aminocarbothiol Pyrroldione. 4th International BAU Drug Desing Congres, 2016-10-13, 2016-10-15, İstanbul, Turkey, 2016. 30
Scientific_Meetings_009.pdf
3. Nural, Y.; Gemili, M.; Ersen, D.; Ülger, M.; Belveren, S.; Poyraz, S.; Serin, M., Synthesis and antimycobacterial activity of Co(III) complexes of N-benzoyl-4,6-dioxo-hexahydropyrrolo[3,4-c]pyrrole-2(1H)-carbothioamide derivatives. 11th International Symposium on Pharmaceutical Science, 2015-06-09, 2015-06-12, Ankara, Turkey, 2015. 22
Scientific_Meetings_002.pdf
2. Poyraz, S.; Nural, Y.; Ülger, M.; Belveren, S.; Gemili, M.; Ersen, D.; Serin, M., Synthesis of Novel Aminocarbo-N-thiol Pyrrolidine Derivatives and Their Antituberculosis Activities. 11th International Symposium on Pharmaceutical Science, 2015-06-09, 2015-06-12, Ankara, Turkey, 2015. 27
Scientific_Meetings_001.pdf
1. Aslan, G.; Tezcan, S.; Ülger, M.; Durukan, H.; Yazıcı, G.; Emekdaş, G., Female Genital Tuberculosis Cases with Different Clinical Symptoms. 35th Annual Congress of the European Society of Mycobacteriology, 2014-06-29, 2014-07-02, Viyana, Austria, 2014. 32
5. Direkel, Ş.; Tezcan, S.; Utku, S.; Aslan, G.; Gökçe, M.; Şahin, F.; Delialioğlu, N., Hidrazon Yapısındaki On Adet Bileşiğin Antileishmanial Aktivitesinin Araştırılması. 1. Ulusal Klinik Mikrobiyoloji Kongresi, 2011-11-12, 2011-11-16, Antalya, Turkey, 2011. 5
4. Tezcan, S.; Ülger, M.; Zeten, D.; Tiftik, E.; Özkul, A.; Emekdaş, G., Mersin Üniversitesi Tıp Fakültesi Kan Merkezi’ne Başvuran Sağlıklı Kan Donörlerinde Batı Nil Virus (BNV) Enfeksiyonunun Araştırılması: Ön Çalışma. III. Ulusal Kan Merkezleri ve Transfüzyon Tıbbı Kongresi, 2010-11-24, 2010-11-28, Antalya, Turkey, 2010. 37
3. Serin, M.; Bekiroğlu, E.; Tezcan, S.; Aslan, G.; Sezgin, O.; Altıntaş, E.; Emekdaş, G., Mersin’de Lamivudin ve Adefovir ile Tedavi Edilmekte Olan Kronik Hepatit B’li Hastalarda İlaç Direncine Sebep Olan HBV Polimeraz Mutasyonlarının Gümüş Boyama Tabanlı “Cycle Sequencing” Metodu ile Araştırılması. 5. Ulusal Moleküler ve Tanısal Mikrobiyoloji Kongresi, 2008-06-24, 2008-06-28, Ankara, Turkey, 2008. 5
2. Aslan, G.; Emekdaş, G.; Ülger, M.; Tezcan, S.; Kaya, A.; Doğu, O.; Kuyucu, N., Tüberküloz menenjit tanısında polimeraz zincir reaksiyonunun kullanılması. 6. Ulusal Mikobakteri Sempozyumu, 2006-11-23, 2006-11-25, Ankara, Turkey, 2006. 30
1. Yıldız, Ç.; Ülger, M.; Aslan, G.; Emekdaş, G., İnsan kanlı ve koyun kanlı agar kullanılarak INH duyarlılığının belirlenmesi. 6. Ulusal Mikobakteri Sempozyumu, 2006-11-23, 2006-11-25, Ankara, Turkey, 2006. 42
28. TEZCAN ÜLGER, S.; ÖZGÜR, D.; ÜLGER, M.; YARAŞ, S.; ALTINTAŞ, E.; SEZGİN, O.; ASLAN, G., Mersin İlinde Kronik Hepatit B Hastalarında Direnç Mutasyonlarının Araştırılması. 2. Ulusal Viroloji Günleri, 2018-03-22, 2018-03-24, , Turkey, . 15
27. Tezcan Ülger, S.; Vural Taşdemir, E.; Ülger, M.; Delialioğlu, N.; Sezgin, O.; Örekici Temel, G.; Emekdaş, G., Mersin İlinde HCV Genotip Dağılımında Yıllar İçindeki Değişikliğin Araştırılması. XXXVII. Türk Mikrobiyoloji Kongresi, 2016-11-16, 2016-11-20, Antalya, Turkey, 2016. 13
Scientific_Meetings_007.pdf
26. Tezcan Ülger, S.; Yazıcı, A.; Ülger, M.; Delialioğlu, N.; Özgür, D.; Oktay, E.; Aslan, G., Psöriazisli Olgularda Human Papillomavirus Varlığının Araştırılması. XXXVII. Türk Mikrobiyoloji Kongresi, 2016-11-16, 2016-11-20, Antalya, Turkey, 2016. 15
Scientific_Meetings_006.pdf
25. Yaşa, E.; Ülger, M.; Utku, S.; Aslan, G., 6-Sübstitüepridazin ve 3(2h)-Pridazinon Türevlerinin Antitüberküloz Aktivitelerinin Araştırılması. XXXVII. Türk Mikrobiyoloji Kongresi, 2016-11-16, 2016-11-20, Antalya, Turkey, 2016. 21
Scientific_Meetings_004.pdf
24. Sönmez, E.; Ülger, M.; Tezcan Ülger, S.; Ersan, R.; Algül, Ö.; Aslan, G., Bazı 2-Sübstitüebenzimidazol Türevi Bileşiklerin Antitüberküloz Aktivitelerinin Araştırılması. XXXVII. Türk Mikrobiyoloji Kongresi, 2016-11-16, 2016-11-20, Antalya, Turkey, 2016. 18
Scientific_Meetings_005.pdf
23. ERTURK, B.; ULGER, M.; TEZCAN ULGER, S.; ALGUL, Ö., Investigation of Antituberculosis Activity of Some 2-Substitued Benzimidazol Derivatives with Agar Proportion Method. 28. Ulusal Kimya Kongresi, 2016-08-15, 2016-08-21, Mersin, Turkey, 2016. 21
Scientific_Meetings_003.pdf
22. Kurnaz, N.; Tezcan Ülger, S.; Ülger, M.; Aslan, G.; Emekdaş, G., İnsanlarda Rift Vadisi Ateşi Virusunun Serolojik Olarak Araştırılması. 1. Ulusal Viroloji Günleri ve Kursu, 2016-02-25, 2016-02-28, Ankara, Turkey, 2016. 17
21. Tezcan, S.; Özgür, D.; Ülger, M.; Aslan, G.; Gürses, İ.; Serin, M.; Giray, B., Servikal Sitoloji Bulgularına Sahip Kadınlarındaki Human Papillomavirus Genotip Dağılımı ve E6/E7 mRNA Ekspresyonu. 1. Ulusal Viroloji Günleri ve Kursu, 2016-02-25, 2016-02-28, Ankara, Turkey, 2016. 12
20. Ülger, M.; Serin, M.; Tezcan, S.; Aslan, G.; Emekdaş, G.; İlvan, A.; Tiftik, E., Tüberküloz Hastalarında Plazma MikroRNA Seviyelerinin Belirlenmesi. 3. Ulusal Klinik Mikrobiyoloji Kongresi, 2015-11-18, 2015-11-22, Antalya, Turkey, 2015. 20
19. Çorabatır Dirim, C.; Tezcan, S.; Aslan, G.; Ülger, M.; Kuyucu, N.; Kaya, A.; Emekdaş, G., Aseptik Menenjit Şüpheli Hastalara Ait BOS Örneklerinde Human Parechovirus ve Enterovirusların Araştırılması. 3. Ulusal Klinik Mikrobiyoloji Kongresi, 2015-11-18, 2015-11-22, Antalya, Turkey, 2015. 12
18. Vural Taşdemir, E.; Ülger, M.; Akdenizli, E.; Tezcan, S.; Aslan, G., Klinik Örneklerde Mycobacterium tuberculosis Varlığının Gösterilmesinde GeneXPert MTB/RIF Sonuçlarının Değerlendirilmesi. 7. Ulusal Mikobakteri Sempozyumu, 2015-05-08, 2015-05-10, Mersin, Turkey, 2015. 20
17. Gürer Giray, B.; Erişik Bağış, G.; Ülger, M.; Ovla, D.; Aslan, G., Löwenstein-Jensen Besiyerinde Mycobacterium tuberculosis İzolasyon Hızına CO2’li İnkübasyonun Etkisi. 7. Ulusal Mikobakteri Sempozyumu, 2015-05-08, 2015-05-10, Mersin, Turkey, 2015. 17
16. Ülger, M.; Direkel, Ş.; Çorabatır Dirim, C.; Ersoy, L.; Tezcan, S.; Aslan, G., Derin Dondurucuda Bir, İki ve Üç Yıl Saklanan Örneklerde MTBC Canlı Kalma Oranları. 7. Ulusal Mikobakteri Sempozyumu, 2015-05-08, 2015-05-10, Mersin, Turkey, 2015. 21
15. Ülger, M.; Ersan, R.; Aslan, G.; Algül, Ö., Yeni Bisbenzimidazol Türevlerinin Antitüberküloz Aktivitelerinin Araştırılması. 7. Ulusal Mikobakteri Sempozyumu, 2015-05-08, 2015-05-10, Mersin, Turkey, 2015. 23
14. Çorabatır, C.; Tezcan, S.; Ülger, M.; Aslan, G.; Sezgin, O.; Otağ, F.; Emekdaş, G., Puerperal Dönemde Bir Tüberküloz Peritonit Olgusu. 2. Ulusal Klinik Mikrobiyoloji Kongresi, 2013-11-10, 2013-11-13, Antalya, Turkey, 2013. 15
13. Ülger, M.; Emekdaş, G.; Aslan, G.; Taş, D.; İlvan, A.; Tezcan, S.; Çalıkoğlu, M., Tüberküloz Hastalarında Sitokin Gen Polimorfizmi ve Genetik Yatkınlığın Belirlenmesi. 2. Ulusal Klinik Mikrobiyoloji Kongresi, 2013-11-10, 2013-11-13, Antalya, Turkey, 2013. 17
12. Gürer Giray, B.; emekdaş, G.; Tezcan, S.; Ülger, M.; Serin, M.; Sezgin, O.; Altıntaş, E., Serum miRNA Profillerinin Hepatit B Virüs (HBV) İnfeksiyonu ve Kronik HBV ile İlişkili Hepatosellüler Karsinomanın Erken Tanısındaki Biyomarkır Olma Potansiyelinin Araştırılması. 9. Ulusal Hepatoloji Kongresi, 2013-05-28, 2013-06-01, İstanbul, Turkey, 2013. 11
11. Çorabatır, C.; Ülger, M.; Yıldırım, Ö.; Kuş, N.; Otağ, F., Korneal Apse Kültüründen Fusarium sp. İzole Edilen Bir Olgu. I. Ulusal Tıbbi Mikoloji Simpozyumu: Geleneksel ve Yeni Tanı Yöntemleri, 2013-04-26, 2013-04-27, İzmir, Turkey, 2013. 20
10. Gülbudak, H.; Aslan, G.; Tezcan, S.; emekdaş, G.; Ersöz, G.; Ülger, M., Yenidoğan Yoğun Bakım Ünitesinden İzole Edilen Acinetobacter baumanni İzolatlarının AP-PCR ve REP-PCR Tekniği ile Klonal Yakınlıklarının İzlenmesi. 7. Ulusal Moleküler ve Tanısal Mikrobiyoloji Kongresi, 2012-06-05, 2012-06-08, Ankara, Turkey, 2012. 10
9. Aydın, F.; Ülger, M.; Emekdaş, G.; Aslan, G.; Günal, S., Mersin İlinde Çiğ Sütlerden Mycobacterium bovis ve Tüberküloz Dışı Mikobakterilerin İzolasyonu ve Tanımlanması. 1. Ulusal Klinik Mikrobiyoloji Kongresi, 2011-11-12, 2011-11-16, Antalya, Turkey, 2011. 20
8. Ülger, M.; Elmas, H.; Utku, S.; Tezcan, S.; Aslan, G.; Emekdaş, G., 6-Sübstitüe-3(2H)-Pridazinon-2-il Aseto/Propiyonato Hidrazit IV Türevlerinin in vitro Antitüberküloz Aktivitelerinin Agar Proporsiyon ve Alamar Blue Yöntemleriyle Belirlenmesi. 1. Ulusal Klinik Mikrobiyoloji Kongresi, 2011-11-12, 2011-11-16, Antalya, Turkey, 2011. 21
7. Aslan, G.; Ülger, M.; Otağ, F.; Apa, D.; Ersöz, G.; Köksel, O.; Doruk, E., Mersin İlindeki Akciğer Dışı Tüberküloz Olgularının Mikrobiyolojik ve Demografik Olarak Değerlendirilmesi. 1. Ulusal Klinik Mikrobiyoloji Kongresi, 2011-11-12, 2011-11-16, Antalya, Turkey, 2011. 13
6. Yarpuzlu, M.; Ülger, M.; Aslan, G.; Tezcan, S.; Köksel, O.; Çalıkoğlu, M.; İlvan, A., Tüberküloz Plörezili 69 Hastanın Mikrobiyolojik Değerlendirilmesi. 1. Ulusal Klinik Mikrobiyoloji Kongresi, 2011-11-12, 2011-11-16, Antalya, Turkey, 2011. 16
5. Tezcan, S.; Ülger, M.; Aslan, G.; Yaraş, S.; Altıntaş, E.; Sezgin, O.; Emekdaş, G., Mersin İli’nde Hepatit C Virusu Genotip Dağılımının Belirlenmesi. 4. Ulusal Viroloji Kongresi, 2011-06-23, 2011-06-26, İstanbul, Turkey, 2011. 17
4. Tezcan, S.; Ülger, M.; Üçbilek, E.; Aslan, G.; Serin, M.; Sezgin, O.; Delialioğlu, N., Hepatit B Virusu (HBV) ile Kronik İnfekte Hastalarda HBV Bazal-Kor Promoter/Prekor Gen Mutasyonları. 4. Ulusal Viroloji Kongresi, 2011-06-23, 2011-06-26, İstanbul, Turkey, 2011. 15
3. Tezcan, S.; Kızıldamar, S.; Ülger, M.; Aslan, G.; Tiftik, E.; Emekdaş, G., Kan Donörlerinde Dengue Virus Varlığının Seroepidemiyolojik Olarak Araştırılması. 4. Ulusal Viroloji Kongresi, 2011-06-23, 2011-06-26, İstanbul, Turkey, 2011. 16
2. Emekdaş, G.; Tezcan, S.; Aslan, G.; Serin, M.; Sezgin, O.; Üçbile, E.; Ülger, M., Mersin İli’nde Kronik Hepatit B hastalarında Hepatit B Virusu genotiplerinin ve Pre-S Gen Varyantlarının Belirlenmesi. 4. Ulusal Viroloji Kongresi, 2011-06-23, 2011-06-26, İstanbul, Turkey, 2011. 2
1. Tezcan, S.; Kızıldamar, S.; Ülger, M.; Aslan, G.; Tiftik, E.; Emekdaş, G., Kan Donörlerinde Dengue Virus Enfeksiyonunun Seroepidemiyolojik Olarak Değerlendirilmesi: Ön Çalışma. III. Ulusal Kan Merkezleri ve Transfüzyon Tıbbı Kongresi, 2010-11-24, 2010-11-28, Antalya, Turkey, 2010. 16
4. Investigation of Toll-Like Receptors 2 and 4 Gene Polymorphisms in Tuberculosis Patients, BAP, Project Number: 2017-2-TP2-2519, 9998 TL, Manager, 2018,Completed. 100
3. Investigation of Antituberculosis Activity of Some 2-Sübstitüebenzimidazol Derivative Compounds with Agar Proportion Method, BAP, Project Number: 2016-1-TP2-1413, 10995 TL, Manager, 2017,Completed. 100
2. INVESTIGATION OF NEW COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS WITH AGAR PROPORSION METHOD, BAP, Project Number: 2015-AP3-1320, 19997 TL, Manager, 2017,Completed. 100
1. Determination of Plasma microRNA Levels in Tuberculosis Patient, TÜBİTAK, Project Number: 114S034, 68850 TL, Manager, 2015,Completed. 100
Projects_001.pdf
19. Fonksiyonel Grup Bulunduran N-Pirolidin-Karbotiyol Benzamid Türevi Bileşiklerin Bazı Metal Komplekslerinin Hazırlanması, Biyoaktivitelerinin İncelenmesi ve İyonlaşma Sabitlerinin Belirlenmesi, BAP, Project Number: 2020-1-AP4-3982, 34178 TL, Researcher, 2022, Continue... 50
18. Sarı Kantoron Çiçeği (Hypericum perforatum L.) ve Aloe vera Bitkilerinden Elde Edilen Bitki Ekstraktların in vitro Antileishmanial Aktivitelerinin Araştırılması, BAP, Project Number: 2019-1-AP4-3489, 21837 TL, Researcher, 2020,Completed. 50
17. Niğde yöresinde endemik olan Hypericum crenulatum Boiss. ve Lysimachia savranii bitki ekstraktlarının in vitro antimikrobiyal aktiviteleri, BAP, Project Number: SSB-2017/02 BAGEP, 20000 TL, Researcher, 2019,Completed. 50
16. Synthesis and characterization of novel thiazole derivatives containing methyl 4,6-dioxo-3,3-diphenyloctahydropyrrolo[3,4-c]pyrrole-1-carboxylate moiety as substituent and investigation of their antibacterial and antituberculosis activities., BAP, Project Number: 2016-2-AP3-1800, 15000 TL, Researcher, 2018,Completed. 50
15. Human Parechovirus, BAP, Project Number: BAP-TF TMAD (CÇ) 2013-2 TU, 19984 TL, Researcher, 2015,Completed. 50
14. Bisbenzimidazol Derivative Compounds, BAP, Project Number: BAP-SBE FKB (RHE) 2014-1 YL, 9987 TL, Researcher, 2015,Completed. 50
13. Serological Investigation of Rift Valley Fever Virus in Humans, BAP, Project Number: BAP-SBE TM (NK) 2013-2 YL, 9990 TL, Researcher, 2014,Completed. 50
12. Etiopathogenesis of Respiratory Viral Infections, BAP, Project Number: BAP TF TTB (ST) 2011-4 GP, 313818 TL, Researcher, 2014,Completed. 50
11. Improving of Microbiology Laboratory Biosafety Systems, BAP, Project Number: BAP-TF TTB (ND) 2013-2 GP, 159745 TL, Researcher, 2014,Completed. 50
10. HPV, BAP, Project Number: BAP SBE TM (DÖ) 2011-7 YL, 9996 TL, Researcher, 2013,Completed. 50
9. HBV Infection Serum miRNA Profile, BAP, Project Number: BAP-SBE TM (BGG) 2011-5 YL, 10000 TL, Researcher, 2012,Completed. 50
8. Acinetobacter baumannii, BAP, Project Number: BAP-SBE TM (HG) 2011-5 YL, 9990 TL, Researcher, 2012,Completed. 50
7. Bacterial Meningitis, BAP, Project Number: BAP-TF TTB (MY) 2010-4 TU, 20000 TL, Researcher, 2012,Completed. 50
6. MODS Method, BAP, Project Number: BAP-TF TTB (GA) 2011-4 GP, 40000 TL, Researcher, 2012,Completed. 50
5. Cytokine Gene Polymorphism, BAP, Project Number: BAP-SBE TM (MÜ) 2010-4 DR, 20000 TL, Researcher, 2011,Completed. 50
4. Dengue Virus, BAP, Project Number: BAP-SBEM TM (SK) 2010-5 YL, 10000 TL, Researcher, 2011,Completed. 50
3. Parvovirus 4, BAP, Project Number: BAP-SBEM TM (ŞG) 2010-5 YL, 9984 TL, Researcher, 2011,Completed. 50
2. Nosocomial Infection, BAP, Project Number: BAP-TF DTB (GS) 2010-3 TU, 19980 TL, Researcher, 2011,Completed. 50
1. Investigation of rpsl and rrs Gene Region Mutations with DNA Squencing in Streptomycin Resistant Mycobacterium tuberculosis Complex Isolates Isolatedin Mersin Province, BAP, Project Number: BAP-SBE TM (MÜ) 2007-1 YL, 5000 TL, Researcher, 2008,Completed. 50
3. Emel SÖNMEZ, Investigation of Antituberculosis Activity of Some 2-Sübstitüebenzimidazol Derivative Compounds with Agar Proportion Method, Graduate School of Health Sciences, Mersin University, Completed. 200
Supervised_Master_Theses_003.pdf
2. Nurcihan BİLTEKİN, Genotyping of Mycobacterium tuberculosis Complex Isolates Isolated from Tuberculosis Patients in a University Hospital by Molecular Methods, Graduate School of Health Sciences, Mersin University, Completed. 200
Supervised_Master_Theses_002.pdf
1. Pınar FIRAT YENER, Investigation of Toll-Like Receptors 2 and 4 Gene Polymorphisms in Tuberculosis Patients, Graduate School of Health Sciences, Mersin University, 2018, Completed. 200
http://tez.yok.gov.tr/UlusalTezMerkezi/tezSorguSonucYeni.jsp
1. MERSIN UNIVERSITESI SAGLIK BILIMLERI DERGISI , [ 2015 : 1 ] . 0
1. Kan Merkezleri ve Transfüzyon Derneği, 2010-10-28, Antalya, Turkey. 25
2. Türk Mikrobiyoloji Cemiyeti Mikobakteri Çalışma Grubu, 2015-05-10, Mersin, Turkey. 25
3. Türk Mikrobiyoloji Cemiyeti Mikobakteri Çalışma Grubu, 2015-05-10, Mersin, Turkey. 25
4. Klinik Mikrobiyoloji Uzmanlık Derneği, 2015-11-21, Antalya, Turkey. 25
5. 1. Ulusal Viroloji Günleri ve Kursu, 2016-02-28, Ankara, Turkey. 25
1. Turkish Society for Microbiology , Member No: 2797, Turkey, 2013-06-24-Continue.
Term | C.Code | Course | Faculty/College/Institute | Department/Program | T-A-C |
Fall | EFMB201 | Biosafety | Faculty of Pharmacy | Pharmacy | 2-0-2 |
Fall | ECZ501 | Graduation Research Project - I | Faculty of Pharmacy | Pharmacy | 1-2-2 |
Fall | ECZ241 | Immunology | Faculty of Pharmacy | Pharmacy | 1-0-1 |
Fall | EMİB 802 | Specialty Area | Institute of Health Sciences | Department of Pharmaceutical M... | 4-0-4 |
Fall | EMİB 801 | Specialty Area | Institute of Health Sciences | Department of Pharmaceutical M... | 4-0-4 |
Fall | EMİB 608 | Molecular Immunology | Institute of Health Sciences | Pharmaceutical Microbiology | 3-0-3 |
Fall | EMİB 508 | Basic Immunology | Institute of Health Sciences | Pharmaceutical Microbiology | 1-0-1 |
Fall | EMİB 502 | Access To Pharmaceutical Microbiology | Institute of Health Sciences | Pharmaceutical Microbiology | 2-0-2 |
Term | C.Code | Course | Faculty/College/Institute | Department/Program | T-A-C |
Spring | ECZ502 | Graduation Research Project - II | Faculty of Pharmacy | Pharmacy | 1-2-2 |
Spring | EMİB 801 | Specialty Area | Institute of Health Sciences | Department of Pharmaceutical M... | 4-0-4 |
Spring | Scientific Research Methods | Institute of Health Sciences | Institute of Health Sciences | 2-0-0 | |
Spring | MMB 513 | Molecular Immunology | Institute of Health Sciences | Molecular Microbiology | 2-0-2 |
Spring | EMİB 605 | Sterilization and Disinfection | Institute of Health Sciences | Pharmaceutical Microbiology | 2-1-3 |
Spring | EMİB 509 | Industriyal Microbiology | Institute of Health Sciences | Pharmaceutical Microbiology | 2-0-2 |
Spring | EMİB 515 | Clinical and Applied Microbiology | Institute of Health Sciences | Pharmaceutical Microbiology | 1-2-2 |
Spring | EMİB 802 | Specialty Area | Institute of Health Sciences | Department of Pharmaceutical M... | 4-0-4 |
Fall | EFMB201 | Biosafety | Faculty of Pharmacy | Pharmacy | 2-0-2 |
Fall | ECZ241 | Immunology | Faculty of Pharmacy | Pharmacy | 1-0-1 |
Fall | ECZ501 | Graduation Research Project - I | Faculty of Pharmacy | Pharmacy | 1-2-2 |
Fall | Scientific Research Methods | Institute of Health Sciences | Institute of Health Sciences | 2-0-0 | |
Fall | EMİB 502 | Access To Pharmaceutical Microbiology | Institute of Health Sciences | Pharmaceutical Microbiology | 2-0-2 |
Fall | EMİB 801 | Specialty Area | Institute of Health Sciences | Department of Pharmaceutical M... | 4-0-4 |
Fall | EMİB 802 | Specialty Area | Institute of Health Sciences | Department of Pharmaceutical M... | 4-0-4 |
Fall | EMİB 508 | Basic Immunology | Institute of Health Sciences | Pharmaceutical Microbiology | 1-0-1 |
Term | C.Code | Course | Faculty/College/Institute | Department/Program | T-A-C |
Spring | ECZ502 | Graduation Research Project - II | Faculty of Pharmacy | Pharmacy | 1-2-2 |
Spring | EMİB 515 | Clinical and Applied Microbiology | Institute of Health Sciences | Pharmaceutical Microbiology | 1-2-2 |
Spring | EMİB 801 | Specialty Area | Institute of Health Sciences | Department of Pharmaceutical M... | 4-0-4 |
Spring | EMİB 802 | Specialty Area | Institute of Health Sciences | Department of Pharmaceutical M... | 4-0-4 |
Spring | Scientific Research Methods | Institute of Health Sciences | Institute of Health Sciences | 2-0-0 | |
Spring | SEM YL | Seminar | Institute of Health Sciences | Institute of Health Sciences | 0-0-0 |
Spring | EMİB 509 | Industriyal Microbiology | Institute of Health Sciences | Pharmaceutical Microbiology | 2-0-2 |
Spring | MMB 513 | Molecular Immunology | Institute of Health Sciences | Molecular Microbiology | 2-0-2 |
Fall | EFMB201 | Biosafety | Faculty of Pharmacy | Pharmacy | 2-0-2 |
Fall | ECZ241 | Immunology | Faculty of Pharmacy | Pharmacy | 1-0-1 |
Fall | ECZ501 | Graduation Research Project - I | Faculty of Pharmacy | Pharmacy | 1-2-2 |
Fall | EMİB 502 | Access To Pharmaceutical Microbiology | Institute of Health Sciences | Pharmaceutical Microbiology | 2-0-2 |
Fall | SEM YL | Seminar | Institute of Health Sciences | Institute of Health Sciences | 0-0-0 |
Fall | EMİB 501 | General Microbiology | Institute of Health Sciences | Pharmaceutical Microbiology | 2-0-2 |
Fall | EMİB 508 | Basic Immunology | Institute of Health Sciences | Pharmaceutical Microbiology | 1-0-1 |
Fall | EMİB 801 | Specialty Area | Institute of Health Sciences | Department of Pharmaceutical M... | 4-0-4 |
Fall | EMİB 802 | Specialty Area | Institute of Health Sciences | Department of Pharmaceutical M... | 4-0-4 |
Fall | Scientific Research Methods | Institute of Health Sciences | Institute of Health Sciences | 2-0-0 |
Term | C.Code | Course | Faculty/College/Institute | Department/Program | T-A-C |
Spring | ECZ502 | Graduation Research Project - II | Faculty of Pharmacy | Pharmacy | 0-5-3 |
Spring | SEM YL | Seminar | Institute of Health Sciences | Institute of Health Sciences | 0-0-0 |
Spring | EMİB 802 | Specialty Area | Institute of Health Sciences | Department of Pharmaceutical M... | 4-0-4 |
Spring | EMİB 515 | Clinical and Applied Microbiology | Institute of Health Sciences | Pharmaceutical Microbiology | 1-2-2 |
Spring | EMİB 509 | Industriyal Microbiology | Institute of Health Sciences | Pharmaceutical Microbiology | 2-0-2 |
Spring | EMİB 801 | Specialty Area | Institute of Health Sciences | Department of Pharmaceutical M... | 4-0-4 |
Fall | ECZ501 | Graduation Research Project - I | Faculty of Pharmacy | Pharmacy | 2-6-5 |
Fall | ECZ241 | Immunology | Faculty of Pharmacy | Pharmacy | 1-0-1 |
Fall | EMİB 502 | Access To Pharmaceutical Microbiology | Institute of Health Sciences | Pharmaceutical Microbiology | 2-0-2 |
Fall | EMİB 501 | General Microbiology | Institute of Health Sciences | Pharmaceutical Microbiology | 2-0-2 |
Fall | SEM YL | Seminar | Institute of Health Sciences | Institute of Health Sciences | 0-0-0 |
Fall | EMİB 802 | Specialty Area | Institute of Health Sciences | Department of Pharmaceutical M... | 4-0-4 |
Fall | EMİB 801 | Specialty Area | Institute of Health Sciences | Department of Pharmaceutical M... | 4-0-4 |
Term | C.Code | Course | Faculty/College/Institute | Department/Program | T-A-C |
Spring | ECZ502 | Graduation Research Project - II | Faculty of Pharmacy | Pharmacy | 0-5-2 |
Spring | EMİB 802 | Specialty Area | Institute of Health Sciences | Department of Pharmaceutical M... | 4-0-4 |
Spring | EMİB 801 | Specialty Area | Institute of Health Sciences | Department of Pharmaceutical M... | 4-0-4 |
Fall | ECZ501 | Graduation Research Project - I | Faculty of Pharmacy | Pharmacy | 2-6-4 |
Fall | ECZ221 | Pharmaceutical Microbiology Practise | Faculty of Pharmacy | Pharmacy | 0-3-1 |
Fall | ECZ241 | Immunology | Faculty of Pharmacy | Pharmacy | 1-0-1 |
Fall | EMİB 802 | Specialty Area | Institute of Health Sciences | Department of Pharmaceutical M... | 4-0-4 |
Fall | EMİB 501 | General Microbiology | Institute of Health Sciences | Pharmaceutical Microbiology | 2-0-2 |
Fall | EMİB 502 | Access To Pharmaceutical Microbiology | Institute of Health Sciences | Pharmaceutical Microbiology | 2-0-2 |
Fall | EMİB 801 | Specialty Area | Institute of Health Sciences | Department of Pharmaceutical M... | 4-0-4 |
Fall | SEM YL | Seminar | Institute of Health Sciences | Institute of Health Sciences | 0-0-0 |
Term | C.Code | Course | Faculty/College/Institute | Department/Program | T-A-C |
Spring | ECZ502 | Graduation Research Project - II | Faculty of Pharmacy | Pharmacy | 0-5-2 |
Spring | EMİB 511 | Control of Microbial Purity On Drugs | Institute of Health Sciences | Pharmaceutical Microbiology | 1-2-2 |
Spring | EMİB 510 | Control of Microbial Purity On Cosmetics | Institute of Health Sciences | Pharmaceutical Microbiology | 1-2-2 |
Spring | EMİB 509 | Industriyal Microbiology | Institute of Health Sciences | Pharmaceutical Microbiology | 2-0-2 |
Spring | EMİB 802 | Specialty Area | Institute of Health Sciences | Department of Pharmaceutical M... | 4-0-4 |
Spring | EMİB 802 | Specialty Area | Institute of Health Sciences | Department of Pharmaceutical M... | 4-0-4 |
Spring | EMİB 515 | Clinical and Applied Microbiology | Institute of Health Sciences | Pharmaceutical Microbiology | 1-2-2 |
Spring | EMİB 801 | Specialty Area | Institute of Health Sciences | Department of Pharmaceutical M... | 4-0-4 |
Spring | EMİB 801 | Specialty Area | Institute of Health Sciences | Department of Pharmaceutical M... | 4-0-4 |
Spring | EMİB 513 | Medical Bacteriology | Institute of Health Sciences | Pharmaceutical Microbiology | 1-2-2 |
Fall | EMİB 501 | General Microbiology | Graduate School of Health Scie... | PHARMACEUTİCAL MİCROBIOLOGY | 2-0-2 |
Fall | EMİB 502 | Access To Pharmaceutical Microbiology | Graduate School of Health Scie... | PHARMACEUTİCAL MİCROBIOLOGY | 2-0-2 |
Fall | EMİB 619 | Graduate School of Health Scie... | PHARMACEUTİCAL MİCROBIOLOGY | 3-0-3 |
Term | C.Code | Course | Faculty/College/Institute | Department/Program | T-A-C |
Spring | EMİB 515 | Clinical and Applied Microbiology | Graduate School of Health Scie... | PHARMACEUTİCAL MİCROBIOLOGY | 1-2-2 |
Spring | EMİB 509 | Industriyal Microbiology | Graduate School of Health Scie... | PHARMACEUTİCAL MİCROBIOLOGY | 2-0-2 |
Spring | EMİB 620 | Food Microbiology | Graduate School of Health Scie... | PHARMACEUTİCAL MİCROBIOLOGY | 3-0-3 |
Spring | TL208 | Parasitology | Vocational School of Health Se... | Medical Laboratory | 2-6-4 |
Fall | EMİB 605 | Sterilization and Disinfection | Graduate School of Health Scie... | PHARMACEUTİCAL MİCROBIOLOGY | 2-1-3 |
Fall | EMİB 502 | Access To Pharmaceutical Microbiology | Graduate School of Health Scie... | PHARMACEUTİCAL MİCROBIOLOGY | 2-0-2 |
Fall | EMİB 501 | General Microbiology | Graduate School of Health Scie... | PHARMACEUTİCAL MİCROBIOLOGY | 2-0-2 |
Fall | TL 211 | Medical Microbiology | Vocational School of Health Se... | Medical Laboratory Techniques | 2-1-3 |
Term | C.Code | Course | Faculty/College/Institute | Department/Program | T-A-C |
Spring | ECZ502 | Graduation Research Project - II | Faculty of Pharmacy | Pharmacy | 0-5-2 |
Spring | EMİB 608 | Molecular Immunology | Graduate School of Health Scie... | PHARMACEUTİCAL MİCROBIOLOGY | 3-0-3 |
Fall | ECZ501 | Graduation Research Project - I | Faculty of Pharmacy | Pharmacy | 2-6-4 |
Fall | ECZ502 | Graduation Research Project - II | Faculty of Pharmacy | Pharmacy | 0-5-2 |
Fall | TL109 | Basic Microbiology | Vocational School of Health Se... | Surgery Room Services | 1-1-2 |
Fall | TL 211 | Medical Microbiology | Vocational School of Health Se... | Medical Laboratory Techniques | 2-1-3 |